The successful acquisition of Sentron by Millar signals a pivotal tactical expansion of the group's sensor development and manufacturing capabilities. This transaction facilitates the integration of Sentron’s specialized fabrication facilities in the Netherlands into Millar’s broader global operations, transforming the combined entity into a comprehensive "one-stop-shop" for sensor-enabled medical devices. The strategic rationale for the move centers on the fusion of Sentron’s expertise in pH and conductivity sensing with Millar’s established leadership in pressure sensor technology. By onboarding this technical specialist, Millar reinforces its ability to serve medical device manufacturers and research institutions that require multi-parameter physiological data. The partnership is designed to leverage Sentron’s advanced manufacturing infrastructure to accelerate the time-to-market for next-generation MEMS solutions. This integration facilitates the creation of a more robust technological platform, providing the strategic depth required to navigate the maturing landscape of digital health and precision diagnostics. The move solidifies Millar’s standing as a primary enabler of breakthroughs in medical understanding and commercialized sensor innovation on a global scale.

This transaction is part of the TMT (Tech, Media, Telecom) industry, which currently tracks an average EBITDA multiple of 13.6x since the beginning of 2026, 3.2% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.